Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.22B 1.08B 972M 899M 814M 1.52B 103B 1.54B 10.74B 4.28B 53.99B 4.07B 3.98B 171B P/E 2026 *
16x
P/E 2027 * 13.5x
Enterprise Value 5.98B 897M 805M 744M 674M 1.26B 85.48B 1.27B 8.9B 3.55B 44.73B 3.37B 3.3B 142B EV / Sales 2026 *
0.34x
EV / Sales 2027 * 0.31x
Free-Float
51.88%
Yield 2026 *
2.87%
Yield 2027 * 3.92%
1 day-2.10%
1 week-3.82%
Current month+17.35%
1 month+18.68%
3 months+11.03%
6 months+1.62%
Current year-2.18%
1 week 12.38
Extreme 12.38
13.36
1 month 10.59
Extreme 10.59
13.42
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 2023-11-21
President 60 2019-11-24
Director of Finance/CFO 44 2023-11-21
Director TitleAgeSince
Chairman 60 2009-05-31
Chairman 61 2009-05-31
Director/Board Member 44 2016-11-15
Date Insider Type Main position Quantity % Market Cap. Importance
5/12/26 Buy

Founder

1,359,000 0.3397%
5/12/26 Sell

Founder

-2,727,600 0.6818%
5/11/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
-2.10%-3.82%-9.69%-43.81% 1.11B
-1.83%-8.44%-42.11%+1.93% 15.09B
-3.51%-2.95%-12.69%-3.00% 6.5B
-3.20%-4.87%-19.24%+0.07% 6.38B
0.00%-8.52%-53.88%-39.87% 5.75B
-14.44%-25.66%-17.58%-36.80% 5.28B
-2.58%-3.37%-1.70%-10.64% 4.65B
-0.16%+1.10%+0.27%-22.87% 3.16B
-4.58%-7.95%-17.72%-20.57% 3.17B
+0.91%-8.76%-38.49%-14.96% 3.14B
Average -3.15%-5.71%-21.28%-19.05% 5.42B
Weighted average by Cap. -3.20%-6.23%-26.52%-12.83%

Financials

2026 *2027 *
Net sales 17.57B 2.64B 2.36B 2.19B 1.98B 3.7B 251B 3.74B 26.14B 10.41B 131B 9.89B 9.68B 417B 18.59B 2.79B 2.5B 2.31B 2.09B 3.91B 266B 3.96B 27.65B 11.01B 139B 10.46B 10.24B 441B
Net income 456M 68.42M 61.39M 56.76M 51.4M 96.03M 6.52B 97.19M 679M 270M 3.41B 257M 251M 10.83B 547M 82M 73.57M 68.02M 61.61M 115M 7.81B 116M 813M 324M 4.09B 308M 301M 12.97B
Net Debt -1.24B -186M -167M -154M -140M -261M -17.7B -264M -1.84B -734M -9.26B -697M -683M -29.4B -1.42B -214M -192M -177M -160M -300M -20.34B -303M -2.12B -844M -10.64B -801M -784M -33.78B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
26-10-27 CN¥12.58 -2.10% 13,644,600
26-10-27 CN¥12.85 -1.91% 9,412,400
26-10-26 CN¥13.10 +3.23% 16,585,949
26-10-23 CN¥12.69 -2.16% 14,880,243
26-10-22 CN¥12.97 -2.11% 15,543,072
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
12.58CNY
Average target price
13.19CNY
Spread / Average Target
+4.85%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock